Serplulimab is the world\'s first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC
NEW YORK,Feb. 5,2025-- The New York Stock Exchange (NYSE) is proud to offer a daily pre-market update directly from the NYSE Trading Floor. Access today\'s NYSE Pre-market update for market insights
PERTH,Australia,Feb. 6,2025-- Argent BioPharma (ASX: RGT) (OTCQB: RGTLF),a clinical-stage biopharmaceutical company brings hope to epilepsy patients.
- Over $137m of aid distributed to 106 countries from Dubai Humanitarian aid hub used by international organisations including UNICEF,IFRC,WHO and WFP
PORT VILA,Vanuatu,Feb. 6,2025-- Vantage Markets,a leading global multi-asset trading platform,is thrilled to announce its partnership with Ferrari,one of the most iconic teams in motorsport. This col
GOTHENBURG,Sweden,Feb. 6,2025-- On Monday 3rd February,ocean energy developer Minesto welcomed Faroese stakeholders,authorities as well as the public to a seminar at the Nordic House in Torshavn. Mart
